These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 6130466)

  • 1. Mebhydrolin napadisylate. A possible cause of reversible agranulocytosis and neutropenia.
    McEwen J; Strickland WJ
    Med J Aust; 1982 Nov; 2(11):523-5. PubMed ID: 6130466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Agranulocytosis associated with mebhydrolin napadisylate (Incidal)].
    Edoute Y; Nagler A; Brenner B
    Harefuah; 1984 Mar; 106(5):208-9. PubMed ID: 6724409
    [No Abstract]   [Full Text] [Related]  

  • 3. Mebhydrolin induced agranulocytosis.
    Young GA; Forrest P; Deveridge SF; Gates RB; Vincent PC
    Aust N Z J Med; 1982 Apr; 12(2):173-6. PubMed ID: 6807274
    [No Abstract]   [Full Text] [Related]  

  • 4. Mianserin: a possible cause of neutropenia and agranulocytosis. Adverse Drug Reactions Advisory Committee.
    Med J Aust; 1980 Dec; 2(12):673-4. PubMed ID: 7219304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-induced neutropenia in the Stockholm region 1973-75: frequency and causes.
    Arneborn P; Palmblad J
    Acta Med Scand; 1978; 204(4):283-6. PubMed ID: 80921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-associated agranulocytosis: 20 years of reporting in The Netherlands (1974-1994).
    van der Klauw MM; Wilson JH; Stricker BH
    Am J Hematol; 1998 Mar; 57(3):206-11. PubMed ID: 9495370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exacerbation of psoriasis, liver dysfunction and thrombocytopenia associated with mebhydrolin.
    McKenna KE; McMillan JC
    Clin Exp Dermatol; 1993 Mar; 18(2):131-2. PubMed ID: 8097681
    [No Abstract]   [Full Text] [Related]  

  • 8. An unusual case of urticaria -- cause and therapy.
    Liddell K
    Curr Med Res Opin; 1975; 3(6):386-7. PubMed ID: 241605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Letter: Neutropenia associated with metiamide.
    Forrest JA; Shearman DJ; Spence R; Celestin LR
    Lancet; 1975 Feb; 1(7903):392-3. PubMed ID: 46534
    [No Abstract]   [Full Text] [Related]  

  • 10. Clozapine-associated neutropenia and agranulocytosis in Argentina (2007-2012).
    Balda MV; Garay OU; Papale RM; Bignone I; Bologna VG; Brandolini A; Prokopez CR; Balasini JI; Baldessarini RJ; Daray FM
    Int Clin Psychopharmacol; 2015 Mar; 30(2):109-14. PubMed ID: 25486383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Successful experiences in use of Mebhydrolin (Incidal) tablets in various dermatologic diseases].
    Yamamoto K; Kinoshita K; Murota S
    Hifuka Kiyo; 1969 Feb; 64(1):39-45. PubMed ID: 4390241
    [No Abstract]   [Full Text] [Related]  

  • 12. Long-term patient monitoring for clozapine-induced agranulocytosis and neutropenia in Korea: when is it safe to discontinue CPMS?
    Kang BJ; Cho MJ; Oh JT; Lee Y; Chae BJ; Ko J
    Hum Psychopharmacol; 2006 Aug; 21(6):387-91. PubMed ID: 16933201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutropenia and agranulocytosis in England and Wales: incidence and risk factors.
    van Staa TP; Boulton F; Cooper C; Hagenbeek A; Inskip H; Leufkens HG
    Am J Hematol; 2003 Apr; 72(4):248-54. PubMed ID: 12666135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Late extrapyramidal hyperkinesia during long-term administration of mebhydrolin].
    Wörz R
    Dtsch Med Wochenschr; 1973 May; 98(21):1071-4. PubMed ID: 4145139
    [No Abstract]   [Full Text] [Related]  

  • 15. Pediatric drug safety signal detection of non-chemotherapy drug-induced neutropenia and agranulocytosis using electronic healthcare records.
    Wei R; Jia LL; Yu YC; Nie XL; Song ZY; Fan DF; Xie YF; Peng XX; Zhao ZG; Wang XL
    Expert Opin Drug Saf; 2019 May; 18(5):435-441. PubMed ID: 31002530
    [No Abstract]   [Full Text] [Related]  

  • 16. Idiosyncratic drug-induced agranulocytosis: the paradigm of deferiprone.
    Pontikoglou C; Papadaki HA
    Hemoglobin; 2010 Jun; 34(3):291-304. PubMed ID: 20524819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug-induced neutropenia--a survey for Stockholm 1973-1978.
    Arneborn P; Palmblad J
    Acta Med Scand; 1982; 212(5):289-92. PubMed ID: 7180577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hematological adverse events in clozapine-treated children and adolescents.
    Gerbino-Rosen G; Roofeh D; Tompkins DA; Feryo D; Nusser L; Kranzler H; Napolitano B; Frederickson A; Henderson I; Rhinewine J; Kumra S
    J Am Acad Child Adolesc Psychiatry; 2005 Oct; 44(10):1024-31. PubMed ID: 16175107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Agranulocytosis probably induced by thenalidine (Sandosten comp.)].
    Holmgren EB; Jonsson M
    Lakartidningen; 1975 Jan; 72(1-2):70-1. PubMed ID: 235058
    [No Abstract]   [Full Text] [Related]  

  • 20. [Preventive use of mebhydrolin in atopic disorders].
    Romański B; Kurek M; Swiatkowski M; Korzeniowska-Zuk E; Pawlik-Miskiewicz K; Wielewska-Kłubo T
    Pol Tyg Lek; 1985 Mar 25-31; 40(12-13):380-3. PubMed ID: 2861598
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.